{"nct_id":"NCT05585632","title":"A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old","status":"COMPLETED","status_verified_date":"2024-03","start_date":"2022-10-14","start_date_type":"ACTUAL","primary_completion_date":"2024-02-28","primary_completion_date_type":"ACTUAL","completion_date":"2024-02-28","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRNA"]}